Skip to main content
Integrative Medicine: A Clinician's Journal logoLink to Integrative Medicine: A Clinician's Journal
. 2017 Apr;16(2):28–38.

Probiotics and Disease: A Comprehensive Summary—Part 4, Infectious Diseases

Margaret G Gasta 1,, Christy B Williamson 1, Crystal M Gossard 1, Jessica M Pizano 1, Cathleen M Burns 1, Keren E Dolan 1, Heather J Finley 1, Emily C Parker 1, Elizabeth A Lipski 1
PMCID: PMC6413636  PMID: 30881235

Abstract

This article series provides a literature review of the disease-specific probiotic strains studied in published clinical trials in humans and animals. The goal of the series is to provide clinically useful tools. The table design allows for quick access to supportive data and will be helpful as a guide for both researchers and clinicians. The first article (part 1) focused on mental health and neurological conditions and the second article (part 2) explored cultured and fermented foods that are commonly available in the United States. The third article (part 3) explored the relationship between bacterial strains and 2 of the most prevalent diseases we have in modern society, cardiometabolic disease and fatigue syndromes. This fourth article (part 4) elucidates the role of the microbiome in infectious diseases. Future articles will review conditions related to infections of the upper respiratory system and ear, nose, and throat; autoimmunity and dermatological conditions; cancer; and gastrointestinal and genitourinary, followed by an article focused on probiotic supplements. This literature review is specific to disease condition, probiotic classification, and individual strain.


The purpose of this review is to investigate disease-specific probiotic strains associated with infectious diseases such as influenza, hepatitis, and human immunodeficiency virus (HIV). This is not an exhaustive review. Considerable research exists on the gut microbiome and role of probiotics; however, this research has not been clearly connected with clinical practice. The authors undertook a review of current literature to explore which specific probiotics and probiotic strains have been used in clinical and laboratory studies. To make this clinically valuable, product names of probiotics and fermented foods have been included. Finished products may vary between manufacturers; therefore, the researchers included brand listings to provide transparency and to facilitate a functional probiotics guide for clinicians. Exclusions of products meeting our criteria do not imply that these products are not effective—we simply were not aware of them.

Methodology

This literature review originated from a group project that was part of the requirements for a course in the doctoral program in functional and clinical nutrition at Maryland University of Integrative Health (Laurel, MD, USA). The student researchers had approximately 2 months to review the literature and synthesize the paper. The authors agreed on format, templates, and execution. Each author researched and wrote sections reviewing probiotics in relation to various health conditions with literature searches conducted in PubMed, Biomed Central, EBSCO Research Premier, PloS One, Cochrane reviews, and topic-specific open-source journals.

The review of specific probiotic products in the professional marketplace and specific probiotics products was performed using Internet searches, primarily Shop Google, in addition to topic-specific databases to search for specific probiotic species including the strains listed in the research. Novel strains were cross-referenced to determine whether the strain was available only for research purposes. If a probiotic combination was used in the research, formulas that closely matched the combination were included. Formulas that contain all or most of the specific probiotics and strains were also included. The food survey focused on bacterial strains in food and includes foods that are commercially produced and commonly available in the refrigerated sections of grocery stores in the United States. Information was gleaned from commercial Web sites and by visiting grocery stores (primarily in California).

Infectious Disease

Infectious diseases infiltrate down to the genomic level. These infections alter the microbiome even in countries that have abundant resources for antiviral medication and adjuvants. This review of infectious disease–associated probiotic strains elucidates the influence of probiotics on the infected individual.

HIV type 1 (HIV-1) infection and the resultant condition of acquired immunodeficiency syndrome (AIDS) affects millions of people, particularly women and children in poor countries such as Africa. The vertical transmission rates from mother to child have increased the epidemic, while finding novel ways to alter the microbiome of both the gastrointestinal system and vagina have proven to reduce these rates.1 Furthermore, supplementation with probiotic strains has demonstrated that alteration of the microbiome can increase CD4+ cells, increase hemoglobin levels, and decrease drug-induced diarrhea.2-5 Infants and children who are infected, and labeled as failure to thrive, regain weight and normalize their body mass index (BMI) when supplemented with either a probiotic-fortified yogurt or infant formula.5,6 Conventional yogurt fermented with additional probiotic supplementation has given promise to alternate therapies for women who do not have access to antiretrovirals.3

Influenza is one of the deadliest respiratory diseases on the planet.7 All efforts should be attempted to increase host immunity and to prophylactically prevent the transmission of influenza. Predetermining the next influenza strain is a moderate process and is flawed with inaccuracies.7 Thus, novel therapies are paramount for those who (1) chose not to be vaccinated, (2) cannot afford to be vaccinated, and (3) are already immunocompromised. Probiotic supplementation has shown great promise in modulating inflammatory cytokines, acting as a direct antiviral as well as a prophylactic therapy against influenza.8-11 The dysbiosis patterns have yet to be fully elucidated for each probiotic strain or “ecosystem” of disease. It is known that bifidobacteria are sensitive to antibiotics and the Enterobacteriaceae family is known for its drug resistance.12 The implications of such sensitivities include a decrease in healthy bifidobacteria species and an overgrowth of pathogens such as Escherichia coli. Although it is atypical to treat influenza with antibiotics initially, these sensitivities within the microbiome become salient when looking at at-risk populations such as older adults or those who are immunocompromised, who often have multiple coinfections.

Hepatitis induced cirrhosis increases bacterial translocation, endotoxemia, and tumor necrosis factor α (TNF-α) production from the diseased liver. Urease-producing bacteria and cognitive dysfunction are positively correlated in cirrhotic patients13 while also increasing the dysbiotic flora found within the gastrointestinal tract. Supplementation with probiotic species has resulted in the normalization of liver function markers (alanine aminotransferase [ALT], asparate amniotransferase [AST], gamma-glutamyltransferase [GGT], lactate dehydrogenase [LDH], and total bilirubin) as well as lowering ammonia levels and improving cognitive performance.13,14

Probiotic supplementation and consumption has also been positively correlated with other infectious diseases such as Epstein-Barr virus (EBV); hand, foot, and mouth disease (HFMDV); and Lyme disease. Research into these areas is in its infancy; however, there is promise in the current supporting literature.

Research Overview: Infectious Disease

Bacterial vaginosis (BV) in women infected with HIV increases the transmission of HIV to their infant 3-fold.3 Hummelen et al2 performed a randomized, double-blind, placebo-controlled trial showing that Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may act as a prophylactic for BV among women with HIV. These 2 strains also normalized vaginal pH leading to the growth of beneficial bacteria. Anukam et al3 also found that supplementation with L reuteri and L rhamnosus GR-1 was more effective than metronidazole gel alone, whereas Martinez et al23 found that the same strains also attenuated vaginal yeast infections when combined with fluconazole. A pilot study using the commercially available yogurts DanActive and YoPlus showed that fungal colonization of the vagina was decreased, especially when consuming the Bifidobacterium and Lactobacillus species in DanActive yogurt.1 Supplementation of probiotics to commercially available yogurt is a novel technique to improve CD4 levels and decrease gastrointestinal discomforts such as diarrhea, flatulence, and nausea. Anukam3 showed that when conventional yogurt fermented with Lactobacillus delbrueckii subsp bulgaricus and Streptococcus thermophilus was supplemented with probiotics L rhamnosus GR-1 and L reuteri RC-14 after 15 to 30 days of consumption, gastrointestinal complaints in all subjects improved and CD4 levels stabilized or increased in Nigerian women. Earlier, Anukam et al3 also showed that L reuteri combined with L rhamnosus GR-1 used in an intravaginal suppository worked better than metronidazole gel in the resolution of pathogenic yeast infiltration. Hummelen2 showed in a randomized control trial that micronutrient fortified yogurt supplemented with L rhamnosus GR-1 improved CD4+ levels and hemoglobin in the absence of retroviral medication. Last, D’Ettorre et al22 showed that supplementation with the following blend of probiotic species resulted in a better outcome than combined antiretroviral treatment alone (Streptococcus salivarius subsp thermophilus, Bifidobacterium breve, Bifidobacterium infantis and Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus, L delbrueckii subsp bulgaricus, and Streptococcus faecium). L reuteri and L rhamnosus GR-1 alone or in combination with probiotic yogurts can also benefit vaginal flora and improve CD4 levels.2

HIV-positive children often have a lower BMI and are frequently labeled as failure to thrive. Cunningham-Rundles et al5 showed that active LP 299V (L plantarum) improved heights in infants with HIV and along with Resta-Lenert17 that a blend of S thermophilus and L acidophilus diminished malabsorption. Trois et al19 found that a probiotic formula containing Bifidobacterium bifidum with S thermophilus increased CD4 counts in HIV-positive children. Steenhout et al20 found that Bifidobacterium lactis (CNCM I-3446) supplemented infant formula resulted in BMIs that were 3.1 g/day higher than those among controls. Cunningham-Rundles et al5 also showed that B lactis in combination with glutamine reduced malabsorption and increased infant weight gain and Salminen et al18 determined that L rhamnosus GG (ATCC 53103) shortened diarrhea associated with coinfection of rotavirus while increasing humoral response. These studies show that targeting the infant with nutrition and probiotics in its early immunomodulation period can result in better health outcomes overall.

Several strains have been directly associated with immunomodulation in patients with HIV. Salva et al38 discovered that L rhamnosus CRL1505 could induce a recovery of B cells. Smits et al16 looked at the lipopolysaccharide (LPS) connection to T-regulatory cells as they express the toll-like receptor 4 when in contact with LPS. They determined that L reuteri and L casei, but not L plantarum, stimulated functionally active T-regulatory cells. Chiba et al15 discovered that L casei produced CD11b+ cells, which increased interleukin (IL)-12 leading to TH1 balance while increasing the secretion of interferon (IFN)-γ. L casei also slightly decreased the proinflammatory cytokine IL-17 produced in Peyer’s patches within the gastrointestinal tract. Last, chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacilli. Nagy et al24 determined that HIV-infected patients might need to avoid L plantarum WCFS1, Lactobacillus gasseri 1SL4, and L casei BL23 owing to increased proinflammatory cytokine production.

Hepatitis C, a common coinfection of HIV-1, has been recognized as a separate cause of low serum micronutrients.39 Microbiome restoration in patients with hepatitis results in increased prostaglandin E2 and a decrease in TNF-α and bacterial translocation.31,32,40 Specifically, Lactobacillus GG (LGG) and the professional product, VSL#3, significantly attenuated liver injury and increased prostaglandin levels. Bifidobacterium, L acidophilus, Enterococcus, Bacillus subtilis, and Enterococcus faecium are the only strains that appear to directly alter hepatitis induced liver damage. This combination of probiotic supplementation increased Bifidobacterium, lowered urine and blood ammonia levels, and decreased damaging endotoxin levels.35 The connection between circulating hepatotoxins, such as mycotoxin, can result in cognitive decline and minimal hepatic encephalopathy. Gratz et al36 found that L rhamnosus GG could specifically bind mycotoxins that alter the microbiome while increasing the mucosal barrier of the intestine. Lata et al34 found that in cirrhotic patients, E coli Nissle could change the microflora while also improving liver function tests. Kirpich et al14 found that after a 5-day treatment with B bifidum and L plantarum 8RA, all liver function tests such as ALT, AST, GGT, LDH, and total bilirubin improved. This contradicts a previous study indicating that there was no effect on any markers of liver function by supplementation of L acidophilus, L bifidus, L rhamnosus, L plantarum, L salivarius, L bulgaricus, L lactis, L casei, and L breve plus fructooligosaccharides (FOS) plus vitamins.37 It is possible that the introduction of FOS and/or vitamins altered the probiotic therapy thereby changing the outcomes. Last, Galland et al13 found that serum ammonia levels decreased and cognitive performance increased with B longum and FOS-82. Galland et al also found that a cocktail of 4 freeze-dried, nonurease producing bacteria (Pediococcus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subsp paracasei, and Lactobacillus plantarum) mixed with beta glucan, inulin, pectin, and resistant starch also had the same effect. Modulating the microbiome in cirrhotic patients can often result in normalization of liver function markers while increasing quality of life.

Several strains of lactobacillus (LGG, L casei strains Shirota DN11400, L gasseri SBT2055, L plantarum DK119, and L brevis KB290) have proven to be prophylactic and have antiviral characteristics against influenza strains.11 L gasseri SBT2055 specifically decreased influenza virus titers, inflammatory IL-6, and bronchoalveolar lavage fluid.10 L brevis KB290 significantly reduced the incidence of influenza infection in children and this effect was most remarkable in unvaccinated children.9 L plantarum DK119 given intranasally or orally resulted in 100% protection against subsequent lethal infections with influenza A viruses. It also prevented significant weight loss and lowered viral loads within the lung tissue in mice.8 Other strains directly target either H7N9, H1N1, and H3N2 strains. The swine flu (H1N1 and H3N2) when treated with E faecium NCIMB10415 was unable to replicate and the probiotic therapy decreased the inflammatory markers TNF-α, TLR-3, and IL-6 while increasing IL-10 in a porcine model.27 Lu et al12 found that C butyricum, B subtilis, and E faecium were helpful against N7N9, but only if the older adult patient did not have additional coinfections. Hu et al26 also later found that B subtilis and E faecium reduced secondary infections in one patient and suggested that the H7N9 influenza infection might decrease intestinal microbial diversity. They noted that lactic acid bacteria recovered more quickly than the Bifidobacterium population during antibiotic cotherapy, indicating a necessity into future research of Bifidobacterium-producing strains in the influenza model.

Probiotic supplementation and consumption has also been positively correlated with other infectious diseases such as EBV, HFMDV, and Lyme disease. Chronic reactivation of EBV has been associated with elite athletes who overtrain.25 Supplementation with probiotics resulted in less secretion of IFN-γ from blood CD4+ T cells and an improvement in clinical symptoms such as sore throat.25 Kombucha fortified with Chinese antiviral herbals inhibits the replication of HFMD in vitro and vivo and may be useful in preventing HFMD outbreaks in cattle and potentially humans.28 Last, probiotics are taking an adjuvant lead in the transmission of the Lyme disease spirochetes. Recombinant L plantarum has shown to prevent the transmission and infection of Borrelia burgdorferi in a mouse model.29 By utilizing commensal species of probiotics, the potential vaccine vector has less allergenic and immunomodulatory effects.

Nutritional Supplements Overview

Professional and commercial dietary supplements containing probiotics are widely available.41 In 2002, it was estimated that more than 100 companies in the United States marketed probiotic supplements and nearly 2 million adults consume them regularly.42 In 2012, probiotic or prebiotic use was the third most commonly used nonvitamin, nonmineral dietary supplement and global sales are projected to reach to $42 billion by the end of 2016.43,44 Using probiotics for general health versus targeting a specific health concern is more complex as the properties of probiotic species are strain specific.45 Unfortunately, research models lack consistency in naming therapeutic strains while in addition, specific strains are often not listed on supplement labels. This challenge prevents the practitioner from distinguishing the researched strain from the supplemental product and is a limitation of these tables. If the researched strain was not readily available on the label or marketing material, the brand, potentially containing the strain, was not included in the table.

The Joint Food and Agriculture Organization of the United Nations/World Health Organization Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics developed guidelines for evaluating probiotics in food.46 A combination of phenotypic and genotypic tests must be performed to determine the strain; however, regulations on species identification are not in place and supplement companies are not required to list this information on labels. During this multiseries review, it was identified that 30 species were specifically isolated for research purposes and were unavailable and another 56 strains were not commercially available. Owing to the wide variety of formulations on the market, lack of knowledge, and poor labeling, it is difficult for practitioners and consumers to determine which brand contains specific strains researched to address a particular health concern.

This table is designed to be a resource to see what is available “at-a-glance.” The brands were chosen by searching the probiotic strain and/ strain-species in Google, several supplement companies, Probiotics Advisor,47 and the Clinical Guide to Probiotic Products. Based on the results and to determine what was commercially available, the search was refined using Google Shopping. In some instances, the supplement company was called to determine if the formula contained a specific species.

Table 1.

Infectious Disease

Infectious Disease Strains Overview Professional and Commercial Products Foods
HIV/AIDS
Hummelen et al1 (2010) L rhamnosus GR-1, L reuteri RC-14 Randomized, double-blind, placebo-controlled trial that indicates these 2 strains may act as a prophylactic for bacterial vaginosis among women with HIV. Probiotics tended to increase the probability of a normal vaginal flora (OR, 2.4; P = .10) and significantly increased the probability of a beneficial vaginal pH (OR, 3.8; P = .02) at follow-up. L rhamnosus GR-1 and L reuteri RC-14:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Metagenics)
Clinicians Flora Restore (Douglas Pharmaceuticals)
None
Anukam et al3 (2008) Conventional yogurt fermented with L delbrueckii subsp bulgaricus; S thermophilus was supplemented with probiotic L rhamnosus GR-1, L reuteri RC-14 In the absence of antiretrovirals, Nigerian adult females with HIV could benefit from yogurt supplemented with L rhamnosus GR-1 and L reuteri RC-14: “The mean CD4 cell count remained the same or increased at 15 and 30 days in 11/12 probiotic-treated subjects compared to 3/12 in the control. Diarrhea, flatulence, and nausea resolved in 12/12 probiotic-treated subjects within 2 days.” L rhamnosus GR-1 and L reuteri RC-14:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Renew Life)
Clinician’s Flora Restore (Douglas Pharmaceuticals)
S thermophilus and L delbrueckii subsp bulgaricus produce yogurt
Hummelen et al2 (2011) Micronutrient fortified yogurt with additional probiotic L rhamnosus GR-1 Randomized, double blind, controlled trial that shows in the absence of antiretrovirals, women with HIV can have improved hemoglobin levels (P = .02) and improved CD4 activity: “An average decline in CD4 count of −70 cells/µL (95% CI: −154 to −15) was observed in the micronutrient, probiotic group versus a decrease of −63 cells/µL (95% CI: −157 to −30) in the micronutrient control group (P = .9)” for the first month and not thereafter. There was no effect on diarrhea frequency. L rhamnosus GR-1:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Renew Life)
Clinicians Flora Restore (Douglas Pharmaceuticals)
Women’s Fem Dophilus (Jarrow Formulas)
Yogurt specified in Hummelen et al2 (2011)
Cunningham-Rundles et al5 (2011)
Gori et al6 (2011)
Infant formula supplemented with B lactis (with glutamine or without) Glutamine treatment reduced malabsorption while those infants who received the B lactis formula gained significantly more weight than controls: “Dietary supplementation with a prebiotic oligosaccharide mixture improved the gut microbiota composition, reducing biomarkers of microbial translocation and T-cell activation.” Now Berrydophilus (kids) One-A-Day TruBiotics (Bayer) Infant formula specified in Cunningham-Rundle et al5 (2011)
Chiba et al15 (2010)
Cunningham-Rundles et al5 (2011)
L casei “L casei induced interleukin (IL)-12 production by CD11b+ cells more strongly than pathogenic Gram-positive and Gram-negative bacteria and promoted the development of T helper type 1 (Th-1) cells leading to high levels of secretion of IFN-γ in vitro while slightly decreasing the IL-17 response to ovalbumin in cells from Peyer’s patches.” L casei:
Widely available in supplement formulas
Mega Flora (Mega Foods)
L casei: Kefir, kvass, lassi, yogurt (Yakult)
Smits et al16 (2005)
Cunningham-Rundles et al5 (2011)
L reuteri, L casei, Not L plantarum “Treg cells express toll-like receptor 4 (TLR-4) and are activated by LPS.” Stimulates functionally activated Treg cells via dendritic C-type lectin DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN). L reuteri with L rhamnosus, Lacidophilus, & FOS:
L Reuteri Plus (Swanson)
L Reuteri:
Primadophilus Reuteri (Nature’s Way)
L casei
Mega Flora (Mega Foods)
L reuteri: None
L casei: Kefir, kvass, lassi, yogurt (Yakult)
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, fermented salsa (not indicated for HIV/AIDS)
Anukam et al3 (2008) Intravaginal probiotic treatment with L reuteri combined with L rhamnosus GR-1 Intravaginal probiotic therapy was more effective than metronidazole gel. Vertical transmission of HIV is 3-fold higher when there is bacterial vaginosis. Must be intravaginal: “Oral L rhamnosus GR-1 and L reuteri RC-1 given in a randomized, double-masked placebo-controlled trial did not enhance response to metronidazole.” L rhamnosus GR-1 and L reuteri RC-14:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Renew Life) Clinicians Flora Restore (Douglas Pharmaceuticals)
None
Anukam et al4 (2006) Yogurt containing
L delbrueckii subsp bulgaricus, S thermophilus, supplemented with L rhamnosus GR-1, L reuteri RC-14
Reduced diarrhea, increased CD4 counts, and stabilized T cells in HIV/AIDS–positive subjects.
Fortified yogurt reduced diarrhea, flatulence, and nausea.
L rhamnosus GR-1 and L reuteri RC-14:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Renew Life) Clinicians Flora Restore (Douglas Pharmaceuticals)
Yogurt containing
L delbrueckii subsp bulgaricus and S thermophilus
(commercial yogurt)
Cunningham-Rundles et al5 (2011)
Resta-Lenert et al17 (2009)
Combination of S thermophilus, L acidophilus Improved malabsorption, which is vital for HIV stabilization: “… ameliorated epithelial dysfunction due to inflammatory cytokines in vitro and in a mouse model of colitis in vivo.” S thermophilus, L acidophilus:
Mega Flora (Mega Foods)
S thermophilus, Lacidophilus:
Innate Flora 5-14 (Complete Care)
S thermophilus: Nancy’s Organic Cultured Soy; cultured coconut and almond yogurts; lassi; kefir
L acidophilus: Nancy’s Organic Yogurts; lassi, kefir
Salminen et al18 (2004)
Cunningham-Rundles et al5 (2011)
L rhamnosus GG, LGG
(ATCC 53103)
Shortens the duration of rotavirus diarrhea; enhances humoral immune responses. Does not work against drug-induced diarrhea: “No benefits were found against protease inhibitor-induced diarrhea induced by inhibitors in this small placebo-controlled, crossover study.” LGG:
Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus-Solgar)
Yogurt and dairy products such as fermented and unpasteurized milk and semihard cheese
Almond Dream Non-dairy Yogurt
Amande Cultured Almond Milk
Trader Joe’s Cultured Coconut Milk
Nancy’s Organic Cultured Soy
Nancy’s Organic Yogurts
Green Valley Organics Lactose-Free Kefir
Nancy’s Organic Lowfat Plain Kefir
Redwood Hill Farm Goat Milk Kefir
KeVita Kombucha Masterbrew
KeVita Kombucha Sparkling Probiotic Drink
Trois et al19 (2008) Probiotic formula containing B bifidum, S thermophilus In children who received the probiotic, the mean CD4+ T-cell count increased in the probiotic group. Controls observed a decrease in CD4+ cells during the same period. There was a concurrent decrease in diarrhea in both groups. B bifidum and S thermophilus:
Mega Foods (Mega Flora)
BIODOPH-7 PLUS (Biotics)
Innate Flora 5-14 (Complete Care)
All yogurts containing “live and active bacteria”
S thermophilus:
Nancy’s Organic Cultured Soy; cultured coconut and almond yogurts
Steenhout et al20 (2009) B lactis (CNCM I-3446)–supplemented infant formula “Weight gain of those taking B lactis was significantly higher than of those not taking B lactis by 3.1 g/day.” BMI was significantly increased in the probiotic group. Isolated for research purposes only. Infant formula
B lactis: Nancy’s Organic Lowfat yogurt, nondairy yogurts, cow’s milk lassi, goat milk yogurt, and kefir
Cunningham-Rundles et al5 (2011) Active LP 299V (L plantarum) 5% or greater improvement in height for 5/9 children with congenital HIV labeled failure to thrive. Height ratio was compared to readings (−3, −2, −1 mo, and day 0) before and 5 mo post therapy. L plantarum 299V:
Ideal Bowel Support (Jarrow Formulas)
Probiotic Supplement (GoodBelly)
Probiotic GX (Nature’s Bounty)
Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Digestive Health Probiotic (Nature Made)
GoodBelly probiotic products
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
Hu et al21 (2013) Bifidobacterium and Lactobacillus found in DanActive/YoPlus yogurts Pilot study showing that Candida/fungal colonization of the vagina was reduced when consuming DanActive (P = .03): “54 % of the women had vaginal fungal colonization during the nonprobiotic yogurt consumption period, 29% during the DanActive period, and 38% during YoPlus yogurt consumption period.” DanActive Yogurt DanActive OR YoPlus
D’Ettorre et al22 (2015) Dietary supplement with probiotics (1 g packet containing S salivarius subsp thermophilus [at least 204 billion CFU], Bifidobacterium–represented by B breve, B infantis and B longum [at least 93 billion CFU], L acidophilus [at least 2 billion CFU], L plantarum [at least 220 million CFU], L casei [220 million CFU], L delbrueckii subsp bulgaricus [at least 300 million CFU], S faecium [at least 30 million CFU]) cART does not modulate inflammatory markers alone. When combined with probiotic therapy, CD4+CD38+HLA-DR+ T and CD8+CD38+HLA-DR+ T cells were significantly lower; CD4 and CD8 surface at T1 normalized and were similar to healthy controls; CD4+ were increased; reduction of acute diarrheal episodes or constipation; reduction of allergic episodes and less fatigue; LBP and CRP were reduced. B breve, B infantis, and B longum, L acidophilus, L plantarum, L casei:
Mega Foods (Mega Flora)
B breve, B infantis, and B longum, L acidophilus, L plantarum, L casei, S salivarius subsp thermophilus:
Innate Flora 5-14 (Complete Care)
B breve: None
B infantis: None
B longum: None
L acidophilus: Lassi, kefir, yogurt
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
L casei: Kefir, kvass, lassi, yogurt, (Yakult)
L delbrueckii subsp bulgaricus: Redwood Hill Farm Goat Milk Kefir
S faecium: Found in conventional yogurt
Martinez et al23 (2009) L rhamnosus GR-1 and L reuteri RC-14 Attenuated the cure rate of yeast vaginitis when combined with fluconazole. Lactobacillus rhamnosus GR-1 and L reuteri RC-14:
Pro-B (Rephresh)
Women’s Fem Dophilus (Jarrow Formulas)
UltraFlora Women’s (Renew Life)
Clinicians Flora Restore (Douglas Pharmaceuticals)
None
Nagy et al24 (2013) May need to avoid L plantarum WCFS1, L gasseri 1SL4, L casei BL-23 Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal lactobacilli. The chronic activation of the immune system may result in decreased immunity. Can cause an upregulation of IL-6, IL-12/IL-23p40, and TNF-α. Precaution: Lactic acid producing bacteria can result in lactic acidosis. Certain probiotics can result in upregulation of proinflammatory cytokines. L plantarum WCFS1, L casei BL23, and L gasseri 1SL4 (isolated for research purposes only). L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
Other strains: None
EBV
Clancy et al25 (2006) Lacidophilus (LAFTIL10) Fatigued athletes often have sore throats and fatigue after intense training, which is consistent with EBV reactivation. They have significantly (P = .02) less secretion of interferon γ from blood CD4+ T cells. LAFTIL10 resulted in secretion of IFN-γ from T cells (P = .01) to levels found in healthy control athletes. LAFTIL10 (DSM Food Specialties, Moorebank, NSW, Australia). NA on commercial supplements. None
Influenza
Hu et al26 (2016) B subtilis, E faecium Reduced/ameliorate secondary infection in 1 patient. H7N9 infection might decrease intestinal microbial diversity. B subtilis and E faecium:
GHT Threelac Probiotic, Natural Lemon Flavor
E faecium:
Enterogenic Concentrate (Integrative Therapeutics)
Ultimate Probiotic (4 billion; Nature’s Secret)
Health-Bac 100 grams (North American Herb & Spice)
None
Park et al8 (2013) L plantarum DK119 Antiviral; potentially modulates host innate immunity of dendritic and macrophage cells, and cytokine production pattern. Dr Formulated Probiotics, Urinary Tract+ (Garden of Life) Isolated from the fermented Korean cabbage food
Wang et al27 (2013) E faecium NCIMB10415 Effective against replication of swine flu, H1N1 and H3N2 strains; decreased TNF-α, TLR-3, and IL-6, and increased IL-10. E faecium directly adsorbed both strains and increased host immunity. Only available in veterinary supplementation. None
Waki et al9 (2014) L brevis KB290 Prophylactic in school children against influenza (P < .001). Results were the most robust in unvaccinated children. Dr Formulated Probiotics Mood + (Garden of Life)
Raw Probiotics Colon Health (Garden of Life)
Probiotic drink containing L brevis KB290 (KB290), isolated from a traditional Japanese pickle suguki.
Nakayama et al10 (2014) L gasseri SBT2055 Effective for preventing influenza virus A/PR8 in mice; probiotic decreased virus titer, IL-6, and bronchoalveolar lavage fluid. The Mx1 and Oas1a genes, increased with pretreatment with LG2055 (critical for the viral clearance in the lung tissues). Isolated for research purposes only. None
Lu et al12 (2014) C butyricum, B subtilis, E faecium Effective against H7N9 in older adults who did not also have coinfections such as Candida species and multidrug-resistant A baumannii and K pneumoniae. CBM588 was ineffective. Fecal microbiota were balanced and immunity restored after antibiotic therapy. C butyricum:
AOR Probiotic-3
MIYARISAN 630 Tablets (Miyarisan)
B subtilis:
Probiotic Formula (Vitaweb)
E faecium:
Enterogenic Concentrate (Integrative Therapeutics
Ultimate Probiotic (4 billion; Nature’s Secret)
Health-Bac 100 grams (North American Herb & Spice)
None
Mortaz et al11 (2013) LGG, L casei strains Shirota and DN114001 Antiviral against influenza and other bacterial/viral infections of the gastrointestinal system. Useful for the prevention and/or treatment of infections. L rhamnosus GG:
Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus-Solgar)
LGG:
None
L casei subsp Shirota: Yakult
L casei DN114001: None
HFMD
Fu et al28 (2015) S pastonanus and A xylinum. The experimental kombucha was prepared by mixing 50 g of sugar, 1 g of (NH4)2SO4, 1 g of KH2PO4, 5 g of licorice (Glycyrrhizae Radix), 2 g of Momordica Grosvenori, 2 g of chrysanthemum (D morifolium), 2 g of green tea (C sinensis) in 1 L of distilled water Kombucha fortified with Chinese antiviral herbs. Inhibits HFMD replication in vitro and vivo and may be useful in preventing HFMD outbreaks. Isolated for research purposes. Kombucha
Lyme Disease
Recombinant
Del Rio et al29 (2008)
Recombinant L plantarum Recombinant L plantarum protects mice from tick-transmitted B burgdorferi infection. Potential vaccine product. NA None
Lyme inflammation
Howarth et al30 (2013)
2 L rhamnosus strains, LGG and LC705 Stimulates levels of IL-1β in macrophages, which are essential for caspase-1 activity. LC705 showed antiviral activity by inducing type 1 interferon-gene activation. L rhamnosus GG:
Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus- Solgar)
L rhamnosus lc705 originates from milk
Hepatitis
Galland13 (2014) B longum, FOS Reduced serum ammonia and improved cognitive performance; alleviates cognitive dysfunction in patients with cirrhosis. B longum and FOS:
Jarro-Dophilus FOS (Jarrow Formulas)
B longum:
Mega Flora (Mega Foods)
5-14 Complete Care (Innate Flora)
None
Galland13 (2014) Cocktail of 4 freeze-dried, nonurease producing bacteria (P pentosaceus, L mesenteroides, L paracasei subsp paracasei, L plantarum) mixed with beta glucan, inulin, pectin, and resistant starch Alleviates cognitive dysfunction in patients with cirrhosis; reduced serum ammonia and improved cognitive performance. L paracasei, and L plantarum:
Nexabiotic
P pentosaceus blend:
Sour Weapon
L plantarum:
Ideal Bowel Support, 10 Billion Organisms V-Capsules (Jarrow Formulas)
Probiotic Supplement (GoodBelly)
Probiotic GX (Nature’s Bounty)
Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Digestive Health Probiotic (Nature Made)
L paracasei in KeVita probiotic drinks
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
P pentosaceus found in beer
Kirpich et al14 (2008) B bifidum, L plantarum 8RA 5-d treatment resulted in lower levels of ALT and AST and significantly increased numbers of both bifidobacteria and lactobacilli in alcoholic patients. A subgroup of mild alcoholic hepatitis patients also had decreased levels of ALT, AST, GGT, LDH, and total bilirubin along with restoration of appropriate commensal species. “Algibif ” and “Algilac”, Microgen/Imbio Moscow-N (Nowgorod, Russian Federation) 8PA3- of 0.9 × 108 CFUs
B bifidum:
Mega Flora (Mega Foods)
L plantarum 8RA:
NA
FOS have been shown to stimulate the growth of Bifidobacterium spp
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
Lam et al31 (2009) LGG Increases basal mucosal prostaglandin E2 production in alcohol fed rats. LGG reduces alcohol induced gut permeability and steatohepatitis. Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus-Solgar)
None
Ewaschuk et al32 (2007) VSL#3 Prevented a breakdown in colonic barrier function, reduced bacterial translocation, reduced tissue TNF-α levels, and significantly attenuated liver injury. VSL#3 – B longum, B infantis, B breve, L acidophilus, L casei, L delbrueckii subsp L bulgaricus, L plantarum, S salivarius subsp thermophiles None
Riordan et al33 (2003) Lactobacillus spp, including
L plantarum and FOS
Reduces primed TNF-α production by peripheral blood mononuclear cells in human cirrhotics. Lactobacillus spp including L plantarum and FOS:
Synbiotic 2000
Lactobacillus spp including L plantarum:
Mega Flora (Mega Flora)
L plantarum:
Ideal Bowel Support, 10 Billion
Organisms V-Capsules (Jarrow Formulas)
Probiotic Supplement (GoodBelly)
Probiotic GX (Nature’s Bounty)
Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Digestive Health Probiotic (Nature Made)
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, salsa
Lata et al34 (2007) E coli Nissle Restoration of “physiological microflora”; reduced endotoxin level in blood (P = .07); and a reduced Child-Pugh score (P = .07) (liver function tests). Mutaflor (Tribute Pharmaceuticals) None
Zhao et al35 (2004) Bifidobacteria + L acidophilus + Enterococcus Hepatitis viruses B and C; Bifidobacterium counts increased with treatment, whereas fecal pH and ammonia levels in feces and blood decreased. Bifidobacterium + L acidophilus:
Mega Flora (Mega Foods)
Bifidobacterium + L acidophilus + Enterococcus:
First Defense Probiotic (Eumaid)
L acidophilus in lassi, kefir, yogurt
Enterococcus in miso
Zhao et al35 (2004) B subtilis + E faecium Hepatitis viruses B and C; Bifidobacterium counts increased with treatment, whereas fecal pH and ammonia levels in feces and blood decreased. Decreased blood levels of endotoxin levels and decreased clostridia. E faecium:
Enterogenic Concentrate (Integrative Therapeutics Ultimate Probiotic (4 billion; Nature’s Secret)
Health-Bac 100 grams (North American Herb & Spice)
None
Gratz et al36 (2010) L rhamnosus GG Mycotoxins are present from gut and liver disease. L rhamnosus GG can bind mycotoxins known to interfere with the intestinal mucosal barrier improving outcomes of those with liver diseases. Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus-Solgar)
L rhamnosus: Almond Dream Non-dairy Yogurt, Amande Cultured Almond Milk, Trader Joe’s Cultured Coconut Milk, Nancy’s Organic Cultured Soy, Nancy’s Organic Cow’s Milk Yogurt, all kefir, KeVita kombucha and sparkling probiotic drinks
Loguercio et al37 (2002) L acidophilus, L bifidus, L rhamnosus, L plantarum, L salivarius, L bulgaricus, L lactis, L casei, L breve + FOG + vitamins No effects found on those with various forms of cirrhosis (HCV, alcoholism, and NASH). L acidophilus, L rhamnosus, L plantarum, L salivarius, L bulgaricus, L lactis, L casei, L breve:
Mega Flora (Mega Foods)
L plantarum:
Ideal Bowel Support, 10 Billion Organisms V-Capsules (Jarrow Formulas)
Probiotic Supplement (GoodBelly) Probiotic GX (Nature’s Bounty) Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Digestive Health Probiotic (Nature Made)
L acidophilus: Lassi, kefir, yogurt
L bifidus: Sheep’s milk yogurt
L rhamnosus: Almond Dream Non-dairy Yogurt, Amande Cultured Almond Milk, Trader Joe’s Cultured Coconut Milk, Nancy’s Organic Cultured Soy, Nancy’s Organic Cow’s Milk Yogurt, all kefir, KeVita kombucha and sparkling probiotic drinks
L plantarum: Fermented vegetables, KeVita probiotic drinks, olives (green), pickled vegetables, fermented salsa
L salivarius: None
L bulgaricus, S thermophilus:
Kefir, all yogurt containing “live and active cultures”
L lactis: Activia Yogurt, Redwood Hill Farm Goat Milk Kefir
L casei: Nancy’s Organic Cow’s Milk Yogurt, all kefirs
L breve:
None

Abbreviations: AIDS, acquired immune deficiency syndrome; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; cART, combined antiretroviral therapy; CFU, colony-forming unit; CI, confidence interval; CRP, C-reactive protein; EBV, Epstein-Barr virus; FOS, fructooligosaccharides; GGT, gamma-glutamyl transferase; HCV, hepatitis C virus; HFMD, hand, foot, and mouth disease; HIV, human immunodeficiency virus; IFN-γ, interferon γ; IL, interleukin; LBP, lipopolysaccharide-binding protein; LDH, lactate dehydrogenase; LGG, Lactobacillus GG; LPS, lipopolysaccharides; NA, not available; NASH, nonalcoholic steatohepatitis; OR, odds ratio; TLR, toll-like receptor; TNF-α, tumor necrosis factor α.

Table 2.

Summary of Nutritional Supplements by Health Concern

Virus Professional or Commercial Supplement Probiotic Strain
EBV LAFTIL10 (DSM Food Specialties, Moorebank, NSW, Australia). NA in commercial supplements. L acidophilus LAFTIL10
HFMD Isolated for research purposes. S pastonanus and A xylinum. The experimental kombucha was prepared by mixing 50 g of sugar, 1 g of (NH4)2SO4, and 1 g KH2PO4, 5 g of licorice (Glycyrrhizae Radix), 2 g of Momordica Grosvenori, 2 g of chrysanthemum (D morifolium), and 2 g of green tea (C sinensis) in 1 L of distilled water.
Hepatitis Mega Flora (Mega Foods)
5-14 Complete Care (Innate Flora)
B longum
Hepatitis Probiotic LGG (Walgreens)
Advanced Multi-Billion (Dophilus-Solgar)
L rhamnosis GG
Hepatitis Ideal Bowel Support, 10 Billion Organisms V-Capsules (Jarrow Formulas)
Probiotic Supplement (GoodBelly)
Probiotic GX (Nature’s Bounty)
Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Digestive Health Probiotic (Nature Made)
Probiotic Balance (Sundown Naturals)
L plantarum
Hepatitis First Defense Probiotic (Emuaid) Bifidobacteria + L acidophilus + Enterococcus
Hepatitis Jarro-Dophilus = FOS (Jarrow Formulas) B longum and FOS
Hepatitis Mega Flora (Mega Foods) B bifidum
Hepatitis Mega Flora (Mega Foods) Lactobacillus spp including L plantarum
Hepatitis Mutaflor (Tribute Pharmaceuticals) E coli Nissle
Hepatitis Nexabiotic L paracasei, L plantarum
Hepatitis NA L plantarum 8RA
Hepatitis Sour Weapon P pentosaceus blend
Hepatitis Synbiotic 2000 Lactobacillus spp including L plantarum and FOS
Hepatitis VSL#3 (Sigma-tau Pharmaceuticals, Inc) VSL#3 - B longum, B infantis, B breve, L acidophilus, L casei, L delbrueckii subsp, L bulgaricus, L plantarum, S salivarius subsp thermophiles
HIV/AIDS Advanced Multi-Billion (Dophilus-Solgar)
Probiotic LGG (Walgreens)
L rhamnosus GG, LGG (ATCC 53103)
HIV/AIDS BIODOPH-7 PLUS (Biotics) B bifidum with S thermophilus
HIV/AIDS Clinicians Flora Restore (Douglas Pharmaceuticals)
Pro-B (Rephresh)
UltraFlora Women’s (Metagenics)
Women’s Fem Dophilus (Jarrow Formulas)
L rhamnosus GR-1 and L reuteri RC-14
HIV/AIDS Digestive Health Probiotic (Nature Made)
Heart Healthy Probiotic Solutions (Dr Sinatra)
Ideal Bowel Support (Jarrow Formulas)
Probiata Digestion Support and Critical Care (Kyolic)
Probiotic Balance (Sundown Naturals)
Probiotic GX (Nature’s Bounty)
Probiotic Supplement (GoodBelly)
L plantarum 299V
HIV/AIDS 5-14 Complete Care (Innate Flora) S thermophiles with L acidophilus
HIV/AIDS 5-14 Complete Care (Innate Flora) B breve, B infantis, and B longum, L acidophilus, L plantarum, L casei, S salivarius subsp thermophilus
HIV/AIDS 5-14 Complete Care (Innate Flora) B bifidum with S thermophilus
HIV/AIDS Mega Flora (Mega Foods) S thermophiles with L acidophilus
HIV/AIDS Mega Flora (Mega Foods) B breve, B infantis, B longum, L acidophilus, L plantarum, L casei
HIV/AIDS Mega Flora (Mega Foods) B bifidum with S thermophilus
HIV/AIDS Primadophilus Reuteri (Nature’s Way) L reuteri and L casei, but not L plantarum
HIV/AIDS NA B lactis (CNCM I-3446) supplemented infant formula
HIV/AIDS Now Berrydophilus (kids)
One-A-Day TruBiotics (Bayer)
B lactis in infant formula
HIV/AIDS Sour Weapon P pentosaceus blend
HIV/AIDS Probiotic LGG (Walgreens) LGG
HIV/AIDS L Reuteri Plus (Swanson) L reuteri and L casei, but not L plantarum
HIV/AIDS Widely available in supplement formulas L casei
Influenza Dr Formulated Probiotics Mood + (Garden of Life) L brevis KB290
Influenza Advanced Multi-Billion (Dophilus-Solgar)
Probiotic LGG (Walgreens)
L rhamnosus GG
Influenza AOR Probiotic-3
MIYARISAN 630 Tablets (Miyarisan)
C butyricum
Influenza Raw Probiotics Colon Health (Garden of Life) L brevis KB290
Influenza Isolated for research purposes only L gasseri SBT2055
Influenza NA L casei strains Shirota and DN114001
Influenza NA in human formula, only veterinary supplements E faecium NCIMB10415
Influenza Probiotic Formula (Vitaweb) B subtilis
Influenza Enterogenic Concentrate (Integrative Therapeutics) L rhamnosus GG, E faecium
Influenza Dr Formulated Probiotics, Urinary Tract+ (Garden of Life) L plantarum DK119
Influenza Enterogenic Concentrate (Integrative Therapeutics)
Ultimate Probiotic (4 billion; Nature’s Secret)
Health-Bac 100 grams (North American Herb & Spice)
E faecium
Influenza GHT Threelac Probiotic, Natural Lemon Flavor B subtilis and E faecium
Lyme Disease Advanced Multi-Billion (Dophilus-Solgar)
Probiotic LGG (Walgreens)
L rhamnosus LGG
Lyme Disease NA Recombinant L plantarum

Abbreviations: AIDS, acquired immune deficiency syndrome; EBV, Epstein-Barr virus; FOS, fructooligosaccharides; HFMD, hand, foot, and mouth disease; HIV, human immunodeficiency virus; LGG, Lactobacillus GG; NA, not available.

Biographies

Margaret G. Gasta, MS, RDN, CCN

Christy B. Williamson, MS, CNS

Crystal M. Gossard, MS, CNS

Jessica M. Pizano, MS, CNS

Cathleen M. Burns, MS, RD

Keren E. Dolan, MS

Heather J. Finley, MS, RD, LD, CEDRD

Emily C. Parker, MS, RD are doctoral students in the doctor of clinical nutrition program

Elizabeth A. Lipski, PhD, CNS, CCN, BCHN, IFMCP, is a professor.

References

  • 1.Hu H, Merenstein DJ, Wang C, et al. Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women. Mycopathologia. 2013;176(0):175-181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hummelen R, Changalucha J, Butamanya N, et al. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynaecol Obstet. 2010;111(3):245-248. [DOI] [PubMed] [Google Scholar]
  • 3.Anukam KC, Osazuwa E, Osemene GI, et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006;8(12-13):2772-2776. [DOI] [PubMed] [Google Scholar]
  • 4.Anukam KC, Osazuwa EO, Osadolor HB, et al. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol. 2008;42(3):239-243. [DOI] [PubMed] [Google Scholar]
  • 5.Cunningham-Rundles S, Ahrné S, Johann-Liang R, et al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients. 2011;3(12):1042-1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gori A, Rizzardini G, Van’t Land, et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the “COPA” pilot randomized trial. Mucosal Immunol. 2011;4(5):554-563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Knobler SL, Mack A, Mahmoud A, Lemon SM, eds. The Threat of Pandemic Influenza: Are We Ready? Washington, DC: National Academies Press; 2005 [PubMed] [Google Scholar]
  • 8..Park MK, Ngo V, Kwon YM, et al. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS ONE. 2013;8(10):e75368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Waki N, Matsumoto M, Fukui Y, Suganuma H. Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: An open-label pilot study. Lett Appl Microbiol. 2014;59(6):565-571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nakayama Y, Moriya T, Sakai F, et al. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep. 2014;4:4638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mortaz E, Adcock IM, Folkerts G, et al. Probiotics in the management of lung diseases. Med Inflamm. 2013;2013:751068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lu H, Zhang C, Qian G, et al. An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection. BMC Infect Dis. 2014;14:359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Galland L. The gut microbiome and the brain. J Med Food. 2014;17(12):1261-1272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kirpich IA, Solovieva N V, Leikhter SN, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Alcohol. 2014;42(8):675-682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chiba Y, Shida K, Nagata S, et al. Well-controlled proinflammatory cytokine responses of Peyer’s patch cells to probiotic Lactobacillus casei. Immunology. 2010;130(3):352-362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smits H, Engering A, van der Kleij D, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005;115(6):1260-1267. [DOI] [PubMed] [Google Scholar]
  • 17.Resta-Lenert SC, Barrett KE. Modulation of intestinal barrier properties by probiotics: Role in reversing colitis. Ann NY Acad Sci. 2009;1165:175-182. [DOI] [PubMed] [Google Scholar]
  • 18.Salminen M, Tynkkynen S, Rautelin, et al. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: A randomized, placebo-controlled, crossover study. HIV Clin. Trials. 2004;5:183-191. [DOI] [PubMed] [Google Scholar]
  • 19.Trois L, Cardoso EM, Miura E. Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J Trop Pediatr. 2008;54:19-24. [DOI] [PubMed] [Google Scholar]
  • 20.Steenhout P, Rochat F, Hager C. The effect of Bifidobacterium lactis on the growth of infants: A pooled analysis of randomized controlled studies. Ann Nutr Metab. 2009;55:334-340. [DOI] [PubMed] [Google Scholar]
  • 21.Hu X, Zhang H, Lu H, et al. The effect of probiotic treatment on patients infected with the H7N9 influenza virus. PLoS ONE. 2016;11(3):e0151976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.D’ Ettorre G, Ceccarelli G, Giustini N, et al. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: Results of the “Probio-HIV” Clinical Trial. PLoS ONE. 2015;10(9):e0137200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Martinez R, Franceschini S, Patta M, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009;48(3):269-274. [DOI] [PubMed] [Google Scholar]
  • 24.Nagy LH, Grishina I, Macal M, et al. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS One. 2013;8(8):e72789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Clancy RL, Gleeson M, Cox A, et al. Reversal in fatigued athletes of a defect in interferon γ secretion after administration of Lactobacillus acidophilus. Brit J Sport Med. 2006;40(4):351-354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hu X, Zhang H, Lu H, et al. The effect of probiotic treatment on patients infected with the H7N9 influenza virus. PLoS ONE. 2016;11(3):0151976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wang Z, Chai W, Burwinkel M, et al. Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro. PLoS ONE. 2013;8(1):53043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fu N, Wu J, Lv L, He J, Jiang S. Anti-foot-and-mouth disease virus effects of Chinese herbal kombucha in vivo. Braz J Microbiology. 2015;46(4):1245-1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Del Rio B, Dattwyler RJ, Aroso M, et al. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with lyme disease. Clin Vacc Immun. 2015;15(9):1429-1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Howarth GS, Wang H. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients. 2013;5(1):58-81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lam E, Tai E, Koo M, et al. Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci. 2007;80:2128-2136. [DOI] [PubMed] [Google Scholar]
  • 32.Ewaschuk J, Endersby R, Thiel D, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007;46(3),841-850. [DOI] [PubMed] [Google Scholar]
  • 33.Riordan S, Skinner N, Nagree, et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003;37:1154-1164. [DOI] [PubMed] [Google Scholar]
  • 34.Lata J, Novotný I, Príbramská V, et al. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: Results of a double-blind randomized study. Eur J Gastroenterol Hepatol. 2007;19,1111-1113. [DOI] [PubMed] [Google Scholar]
  • 35.Zhao H, Wang H, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004;5(2):64-67. [DOI] [PubMed] [Google Scholar]
  • 36.Gratz S W, Mykkanen H, El-Nezami HS. Probiotics and gut health: A special focus on liver diseases. World J Gastroenterol. 2010;16(4):403-410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Loguercio C, De Simone T, Federico A, et al. Gut-liver axis: A new point of attack to treat chronic liver damage? Am J Gastroenterol. 2002;97(8):2144-2146. [DOI] [PubMed] [Google Scholar]
  • 38.Salva S, Merino M, Agüero G, Gruppi A, Alvarez S. Dietary supplementation with probiotics improves hematopoiesis in malnourished mice. PLoS ONE. 2012;7(2):31171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Forrester JE, Wang XD, Knos TA, Borek CG, Tang AM, Johanson EJ. Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use. J Public Health Policy. 2009;September;30(3):285-299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Forsyth C, Farhadi A, Jakate S, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43:163-172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sanders ME. Probiotics: Definition, sources, selection, and uses. Clin Infect Dis. 2008;46(suppl 2):S58-S56. [DOI] [PubMed] [Google Scholar]
  • 42.Sanders ME. Probiotics, strains matter. Functional Foods & Nutraceuticals Magazine. 2007;48:36-41. [Google Scholar]
  • 43.Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Nat Health Stat Rep. 2015;79:1. [PMC free article] [PubMed] [Google Scholar]
  • 44.Berkley Wellness. Probiotics pros and cons. http://www.berkeleywellness.com/supplements/other-supplements/article/probiotics-pros-and-cons. Published March 3, 2014. Accessed March 5, 2017.
  • 45.Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: What are the risks? Am J Clin Nutr. 2006;83(6):1256-1264. [DOI] [PubMed] [Google Scholar]
  • 46.Venugopalan V, Shriner KA, Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis. 2010;16(11):1661-1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hawrelak J. Probiotic Advisor Web site. https://www.probioticadvisor.com/. Accessed March 30, 2017.
  • 48.Skokovic-Sunjic D. Clinical guide to probiotic products. US Probiotic Guide Web site. http://usprobioticguide.com/. Published 2016. Accessed December 24, 2016.

Articles from Integrative Medicine: A Clinician's Journal are provided here courtesy of InnoVision Media

RESOURCES